Skip to main content

SI-BONE, Inc.

corporate_fare Company Profile

SI-BONE, Inc.

SIBN·NASDAQ·Industrial Applications And Services·CIK 0001459839

SI-BONE, Inc. develops innovative procedural solutions for compromised bone, focusing on biomechanical design and anatomy-specific innovation. The company specializes in minimally invasive treatment for sacroiliac joint dysfunction and degeneration, addressing challenges in low-density bone in the sacrum. Leveraging its additive manufacturing (3D-printing) experience from sacroiliac fusion, SI-BONE has expanded its technology platform to meet needs in thoracolumbar fixation and fusion, and pelvic trauma. SI-BONE markets its products primarily through a direct sales force and third-party sales agents in the United States. In other countries, sales are conducted via a combination of a direct sales force, sales agents, and resellers. As of December 31, 2025, over 140,000 procedures have been performed using SI-BONE products since the introduction of iFuse in 2009. The company's products include patented titanium implants, the instruments for implantation, and implantable bone products. Key implant product lines include iFuse, launched in 2009; iFuse 3D, launched in 2017; iFuse TORQ, launched in 2021; iFuse Bedrock Granite, launched in 2022; and iFuse INTRA and iFuse TORQ TNT, both launched in 2024. In the United States, iFuse, iFuse 3D, iFuse TORQ, and iFuse Bedrock Granite are cleared for sacroiliac joint dysfunction, adult spinal deformity, and pelvic trauma applications. iFuse TORQ TNT is cleared for pelvic trauma and sacroiliac joint dysfunction. In the European Economic Areas, iFuse, iFuse 3D, and iFuse TORQ are CE marked for sacroiliac joint dysfunction, adult spinal deformity, and pelvic fracture fixation. The iFuse implant is a machined triangular titanium implant with a triangular cross section and porous surface, authorized by the FDA in November 2008 and CE-Marked in November 2010. iFuse 3D is a second-generation, additively-manufactured triangular titanium implant with a porous surface and fenestrated design.

SI-BONE, Inc. (NASDAQ:SIBN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for SIBN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for SIBN spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • SI-BONE Q3 Revenue Up 14.5% to $55.7M; Operating Cash Flow Turns Positive
  • SI-BONE Posts 8-Cent Q3 Loss Per Share
  • FDA Clears SI-BONE's iFuse Granite Onyx for Spinal Fusion, Expanding Beyond Pelvis
  • SI-BONE Recalls 98 iFuse TORQ Implants Over Sterility Risk; Two Already Implanted
  • SI-BONE Q2 Revenue Climbs 15%, Loss Narrows; CEO Adopts 10b5-1 Plan

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$200.93M
Net Income
-$18.9M
Diluted EPS
-$0.44
Op. Cash Flow
-$675K
Free Cash Flow
-$9.09M
Gross Profit
$159.88M
Operating Income
-$22.33M
Cash & Equivalents
$42.24M
Total Debt
$35.57M
Debt / Equity
0.20×
Net Margin
-9.4%
Shares Outstanding
43.65M sh
Source: 10-K · filed 2026-02-24 · accession 0001459839-26-000036

Short Interest & Short Volume

6.84 days to cover

FINRA reported short interest of 4,526,148 shares in SIBN as of the October 30, 2026 settlement, a 3.8% decrease from the prior period — about 6.8 days to cover at its recent average daily volume. On November 20, 2026, 38.5% of SIBN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,526,148 shares as of October 30, 2026
Change vs prior period▼ 3.8%
Days to cover6.84 at avg daily volume of 661,919
Daily short volume (FINRA facilities)38.5% of 336,222 shares on November 20, 2026
5-day average short volume21.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$24.4 +2.82% today
52-week range · as of 2026-11-03 $11.48 – $24.4
Market cap
$1.07B
Volume
801.1K (0.9× avg)
3-mo avg 861.6K
Live data · 2026-11-21 02:18 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed SIBN - Latest Insights

SIBN
Nov 03, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.77
Real-time Price: $24.40 info
Change: +$0.630 (+3%) info
Market Cap: $1.071B info
SIBN
Nov 02, 2026, 4:09 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.63
Real-time Price: $24.40 info
Change: +$3.77 (+18%) info
Market Cap: $1.071B info
SIBN
Sep 28, 2026, 4:09 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $19.14
Real-time Price: $24.40 info
Change: +$5.26 (+27%) info
Market Cap: $1.071B info
SIBN
Sep 11, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.39
Real-time Price: $24.40 info
Change: +$5.01 (+26%) info
Market Cap: $1.071B info
SIBN
Aug 04, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $18.44
Real-time Price: $24.40 info
Change: +$5.96 (+32%) info
Market Cap: $1.071B info
SIBN
Aug 03, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $16.50
Real-time Price: $24.40 info
Change: +$7.90 (+48%) info
Market Cap: $1.071B info
SIBN
Aug 03, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.86
Real-time Price: $24.40 info
Change: +$7.54 (+45%) info
Market Cap: $1.071B info
SIBN
May 11, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.00
Real-time Price: $24.40 info
Change: +$11.40 (+88%) info
Market Cap: $1.071B info
SIBN
May 11, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.75
Real-time Price: $24.40 info
Change: +$11.65 (+91%) info
Market Cap: $1.071B info
SIBN
May 11, 2026, 4:09 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $12.55
Real-time Price: $24.40 info
Change: +$11.85 (+94%) info
Market Cap: $1.071B info
SIBN
Feb 24, 2026, 4:19 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $15.20
Real-time Price: $24.40 info
Change: +$9.20 (+61%) info
Market Cap: $1.071B info
SIBN
Feb 23, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.50
Real-time Price: $24.40 info
Change: +$7.90 (+48%) info
Market Cap: $1.071B info
SIBN
Jan 12, 2026, 9:11 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.00
Real-time Price: $24.40 info
Change: +$5.40 (+28%) info
Market Cap: $1.071B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets